Run the two placements PaiPaiWang could put a number to forward at market and the year takes shape: $26 million of CXMT pre-IPO stock [6], against a Shanghai debut that ran more than fivefold in July plus another 20% since [7], carries at roughly $156 million [2], and the $5.8 million of Unitree [8], up 460% on day one and off about 27% since [10], marks near $23.7 million [3]. That is about $180 million against $31.8 million of cost [1][4], all of it unrealised marks rather than cash [19].
The more interesting term, or rather the one that tells you who is doing what, is the lock-up. DeepSeek took 2.31% of the Unitree offering as one of nine strategic investors and agreed to sit still for 36 months, three times the 12 months most strategic backers accepted [9][6]. Hutong Research's Sigrid Wang draws the line cleanly: the quant funds traded Unitree as an investable asset, the lab used its balance sheet to buy a relationship in the future AI stack [13]. Ke Zong, a Shanghai-based portfolio manager, told CNBC that Liang's team are still traders at heart, inclined to chase maximum upside [16], and yet a trader who accepts a three-year lock has moved past trading into paying for a seat.
Nearly half of the two affiliates' allocations this year went into semiconductors and their supply chain [12], which reads less like a factor tilt than like a reading of the state catalogue. Rhodium's Ciel Qi says Beijing's push to keep strategically important tech firms listing at home has created lucrative pre-IPO opportunities, and that maximising returns in China increasingly requires investing in line with Beijing's agenda [4]. Brookings' Kyle Chan adds the reflexive part: a DeepSeek or a Liang fund on the book lends attention and legitimacy, with a potential extra lift to the valuation those same backers are then marked against [14]. Beijing's endorsement of both, in turn, improved their access to marquee listings [15].
This is probably the wrong emphasis, but the more durable fact sits on the funding side. Qi says High-Flyer's revenue has become unstable, and that as DeepSeek's capital and compute needs grow it may be unable to rely on the fund [3]; July showed the mechanism, with eight of the fund's nine products in the red as the global AI-chip rout spilled into momentum quant trades, before Chinese quants rebounded in August [11]. A patron whose monthly P&L moves with the same chip complex its lab is trying to buy from makes a wobbly treasury, which is the plainest explanation for DeepSeek going outside for money [2]. The counter-thesis is respectable: the placement book may be small next to High-Flyer's trading business, the lab's outside round may be about partners rather than a compute bill, and Unitree's 27% give-back is a reminder that a policy-lifted mark is not a price you can sell into [10][18]. I would drop this read if DeepSeek's next raise turns out modest and strategic, or if the affiliates rotate out of semiconductors once the listing queue thins. Neither High-Flyer nor DeepSeek responded to CNBC's requests for comment [17].
